MedCost Clear Cost calculator

Drugs / Yeztugo

Yeztugo cost

lenacapavir · Gilead. Every official price for Yeztugo, side by side, with who pays it.

Short answer

FDA approved Yeztugo (lenacapavir) on Jun 18, 2025. We found no list price (wholesale acquisition cost) for Yeztugo on Gilead's own pages, so we do not show one. Medicare Part B pays up to $16.016 per mg for Yeztugo injection for HIV PrEP and $617.946 per 300 mg for Yeztugo tablet for HIV PrEP (October 1, 2026 to December 31, 2026).31

Source: FDA and CMS · checked Nov 7, 2026

Yeztugo: the official numbers, by situation

PriceAmountWhose price, and who it applies toDate
List price Not published We found no list price (wholesale acquisition cost) for Yeztugo on Gilead's own pages, so we do not show one. —
Medicare Part B payment limit
per mg, Yeztugo injection for HIV PrEP
$16.0161 What Medicare pays when the drug is paid under Part B (for example, given in a clinic). CMS lists Part B coinsurance for this code as 0%. October 1, 2026 – December 31, 2026
Medicare Part B payment limit
per 300 mg, Yeztugo tablet for HIV PrEP
$617.9461 What Medicare pays when the drug is paid under Part B (for example, given in a clinic). CMS lists Part B coinsurance for this code as 0%. October 1, 2026 – December 31, 2026

None of these is your price at the counter: that depends on how you pay. Details and sources for each number are further down.

FDA approval

Every official price

PriceAmountWhat it isDate
Maker's list price (WAC) Not published We found no list price (wholesale acquisition cost) for Yeztugo on Gilead's own pages, so we do not show one. —
Medicare Part B payment limit
Yeztugo injection for HIV PrEP (lenacapavir) · HCPCS J0738
$16.0161 Per 1 mg, when given in a clinic or hospital outpatient setting and paid under Part B. CMS lists Part B coinsurance for this code as 0%. October 1, 2026 – December 31, 2026
Medicare Part B payment limit
Yeztugo tablet for HIV PrEP (lenacapavir) · HCPCS J0752
$617.9461 Per 300 mg, when given in a clinic or hospital outpatient setting and paid under Part B. CMS lists Part B coinsurance for this code as 0%. October 1, 2026 – December 31, 2026
Pharmacy acquisition cost (NADAC)Not listedThis drug is not in the NADAC survey, which covers drugs dispensed by retail pharmacies.—

These are prices the drug company, Medicare and pharmacies use. What you pay depends on your coverage; see below. CMS notes that a code's presence in its payment file does not by itself mean Medicare covers the drug.2

With Medicare

With commercial insurance or no insurance

Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.

Official sources for this page (6)
  1. “The absence or presence of a HCPCS code and the payment allowance limits in this table does not indicate whether Medicare covers a drug.”
  2. “NDA220018 ORIG-1 approved 20250618”
  3. “YEZTUGO is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition.”
  4. “Medicare now covers Yeztugo (lenacapavir) for Pre-exposure Prophylaxis (PrEP).”
    CMS: Medicare coverage of PrEP · as of Oct 25, 2026
  5. “Effective for claims with dates of service on or after September 30, 2024, CMS covers PrEP using antiretroviral drugs approved by the U.S. Food and Drug Administration (FDA) to prevent HIV in individuals at increased risk of HIV acquisition.”

Did this page answer your question?